Sharon Hemond Hrynkow Net Worth & Insider Trades
Sharon Hemond Hrynkow - Chief Scientific Officer, Cyclo Therapeutics, Inc
What is Sharon Hemond Hrynkow's Net Worth?
The current estimated net worth of Cyclo Therapeutics, Inc's Chief Scientific Officer, Sharon Hemond Hrynkow, is estimated to be about $78.64K . Sharon Hemond Hrynkow owns about 335,000 units of Cyclo Therapeutics, Inc common stock. In the last 2 years at Cyclo Therapeutics, Inc, Sharon Hemond Hrynkow has sold an estimated value of $0 worth.
What is Sharon Hemond Hrynkow's Past Insider Trading?
Sharon Hemond Hrynkow's largest purchase order was 10,000 units , worth over $2.48K on August 2, 2019. In total, Sharon Hemond Hrynkow has made about 6 transactions over 2 years of their time at Cyclo Therapeutics, Inc. Sharon Hemond Hrynkow usually trades in July, August, December, June, September and April, with the busiest year in 2019.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sharon Hemond Hrynkow
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Sharon Hemond Hrynkow's' Mailing Address?
- Mailing address is 4816 King Solomon Drive Annadale VA 22003 VA
What are Cyclo Therapeutics, Inc's Past Insider Trades?
Cyclo Therapeutics, Inc's most recent insider trade came on November 25, 2020 by Joshua M Fine who bought 25,000 units worth $1.92K . In the last 17 years, insiders at Cyclo Therapeutics, Inc have sold an estimated value of $518.35K and bought an estimated value of $1.43M worth of shares. Insider trading is most common in April, with the busiest year in 2018. The most active traders at the company are Francis Patrick Ostronic, Director, N. Scott Fine, Chief Executive Officer, and Markus Sieger, Director .
Cyclo Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |